Hindalco Industries Limited
6,151words
6turns
0analyst exchanges
0executives
Key numbers — 29 extracted
157 million
14%
180 million
11%
484 million
4%
5%
1%
4.1 billion
290 million
196 million
300 million
Risks & concerns — 2 flagged
Other important factors are discussed under the captions "Risk Factors" and “Management’s Discussion and Analysis” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2023 and in our Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2023.
— Ref
Other important factors are discussed under the captions "Risk Factors" and “Management’s Discussion and Analysis” in our Annual Report on Form 10-K for the fiscal year ended March 31, 2023 and as the same may be updated from time to time in our quarterly reports on Form 10-Q, or in other reports which we from time to time file with the SEC.
— Special Items
Advertisement
Speaking time
1
1
1
1
1
1
Opening remarks
Ref
a. Regulation 30 of the Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘Listing Regulations’) ISIN: INE038A01020 b. ________________________________________________________________________________ Please find enclosed herewith the Press release and Investor Presentation of Novelis Inc. for its results of Q2 FY24 ending September 30, 2023. The above information will also be made available on the Company’s website www.hindalco.com and Novelis Inc. website www.novelis.com Sincerely, for Hindalco Industries Limited Geetika Anand Company Secretary & Compliance Officer Hindalco Industries Limited Corporate Office: 6th & 7th Floor, Birla Centurion, Pandurang Budhkar Marg, Worli, Mumbai – 400030, India | T: +91 22 66626666/62610555 | F: +91 22 62610400/62610500 Registered Office: 21st Floor, One International Center, Tower 4, Near Prabhadevi Railway Station, Senapati Bapat Marg, Prabhadevi, Mumbai – 400013 | W: www.hindalco.com |E: hilin
Investor Contact
Megan Cochard +1 404 316 7525 julie.groover@novelis.adityabirla.com +1 404 760 4170 megan.cochard@novelis.adityabirla.com 3 Novelis Inc. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (unaudited) (in millions) Net sales Cost of goods sold (exclusive of depreciation and amortization) Selling, general and administrative expenses Depreciation and amortization Interest expense and amortization of debt issuance costs Research and development expenses Loss on extinguishment of debt, net Restructuring and impairment expenses, net Equity in net income of non-consolidated affiliates Other (income) expenses, net Income from continuing operations before income tax provision Income tax provision Net income from continuing operations Loss from discontinued operations, net of tax Net income Net loss attributable to noncontrolling interest Three Months Ended September 30, 2022 2023 2022 $ 4,107 $ 4,799 $ 8,198 $ 9,888 6,978 8,405 3,477 182 136 78 23 5 4 4,140 181 134 65 23 — 1 356 267 155 48 5 7 (4)
Current assets
Cash and cash equivalents Accounts receivable, net — third parties (net of allowance for uncollectible accounts of $7 and $5 as of September 30, 2023, and March 31, 2023, respectively) — related parties Inventories Prepaid expenses and other current assets Fair value of derivative instruments Assets held for sale Total current assets Property, plant and equipment, net Goodwill Intangible assets, net Investment in and advances to non–consolidated affiliates Deferred income tax assets Other long-term assets — third parties — related parties Total assets LIABILITIES AND SHAREHOLDER’S EQUITY
Current liabilities
Current portion of long-term debt Short-term borrowings Accounts payable — third parties — related parties Fair value of derivative instruments Accrued expenses and other current liabilities Return of capital payable - related party Total current liabilities Long-term debt, net of current portion Deferred income tax liabilities Accrued postretirement benefits Other long-term liabilities Total liabilities Commitments and contingencies Shareholder’s equity Common stock, no par value; unlimited number of shares authorized; 1,000 shares issued and outstanding as of September 30, 2023, and March 31, 2023 Additional paid-in capital Retained earnings Accumulated other comprehensive loss Total equity of our common shareholder Noncontrolling interest Total equity Total liabilities and equity September 30, 2023 March 31, 2023 $ 1,158 $ 1,498 1,811 135 2,761 175 121 1 6,162 5,228 1,073 568 873 152 1,751 156 2,729 178 145 3 6,460 4,900 1,076 589 877 166 275 2 14,333 $ 293 3 14,364 51 $ 692 88 671
Special Items
Loss on extinguishment of debt, net Metal price lag Restructuring and impairment expenses, net Tax effect on special items 5 22 4 — 24 1 5 17 7 (8) (6) (7) — 21 2 (4) Net income from continuing operations, excluding special items $ 180 $ 203 $ 335 $ 510 8 Segment Information (unaudited) The following tables present selected segment financial information (in millions, except shipments which are in kilotonnes). Selected Operating Results Three Months Ended September 30, 2023 Adjusted EBITDA North America Europe Asia South America Eliminations and Other Total $ 208 $ 100 $ 82 $ 93 $ 1 $ 484 Shipments (in kt) Rolled products – third party Rolled products – intersegment Total rolled products 390 — 390 252 4 256 155 20 175 136 8 144 — (32) (32) 933 — 933 Selected Operating Results Three Months Ended September 30, 2022 Adjusted EBITDA North America Europe Asia South America Eliminations and Other Total $ 191 $ 73 $ 113 $ 127 $ 2 $ 506 Shipments (in kt) Rolled products – third party Rolled pro
Advertisement